Clovis Oncology to Announce Fourth Quarter/Fiscal Year 2018 Financial Results and Host Webcast Conference Call on February 26
February 12, 2019
BOULDER, Colo.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24CLVS&src=ctag” target=”_blank”gt;$CLVSlt;/agt;–Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its fourth
quarter/fiscal year 2018 financial results on Tuesday, February 26,
2019, before the open of the U.S. financial markets. Clovis’ senior
management will host a conference call and live audio webcast at 8:30
a.m. ET to discuss the company’s results in greater detail.
The conference call is being webcast and can be accessed from the Clovis
Oncology website at www.clovisoncology.com.
A replay of the webcast will be available for 30 days.
Conference Call Details
Clovis will hold a conference call to discuss Q4/FY 2018 results on
Tuesday, February 26, at 8:30am ET. The conference call will be
simultaneously webcast on the Company’s web site at www.clovisoncology.com,
and archived for future review. Dial-in numbers for the conference call
are as follows: US participants 866.393.4306, International participants
734.385.2616, conference ID: 6675335.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops, with partners, diagnostic
tools intended to direct a compound in development to the population
that is most likely to benefit from its use. Clovis Oncology is
headquartered in Boulder, Colorado; please visit www.clovisoncology.com
for more information, including additional office locations in the U.S.
and Europe.
Contacts
Clovis Investor Contacts:
Anna Sussman
303.625.5022
asussman@clovisoncology.com
or
Breanna
Burkart
303.625.5023
bburkart@clovisoncology.com